Lisdexamfetamine, marketed as Vyvanse, is a prescription drug approved in the country for addressing Attention-Deficit/Hyperactivity Disorder in youngsters and adults . The medication functions as a prodrug, https://apo-lisdexamfetamine-pri319759.ampedpages.com/lisdexamfetamine-in-canada-a-comprehensive-overview-70614689